DIMAZON 50 MG/ML SOLUTION FOR INJECTION
Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
Caracteristicilor produsului
(SPC)
15-07-2016
Unele documente pentru acest produs nu sunt disponibile în prezent, puteți trimite o solicitare la serviciul nostru pentru clienți și vă vom anunța de îndată ce vom putea să le obținem.
Trimite cerere.
Trimite cerere.
Ingredient activ:
FUROSEMIDE
Disponibil de la:
Intervet Ireland Limited
Codul ATC:
QC03CA01
INN (nume internaţional):
FUROSEMIDE
Dozare:
50 Mg/Ml
Forma farmaceutică:
Solution for Injection
Tip de prescriptie medicala:
POM
Grupul Terapeutică:
Bovine, Canine, Equine - Food, Feline
Zonă Terapeutică:
Furosemide
Indicații terapeutice:
Cardiovascular
Statutul autorizaţiei:
Authorised
Data de autorizare:
1995-10-01
Caracteristicilor produsului
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Dimazon 50 mg/ml Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
A slightly yellowing fluid
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, horses, dogs and cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Supportive therapy in all cases in which non inflammatory accumulation of fluid of various origins should be
reabsorbed from tissue body cavities, joints, tendon sheaths etc. by means of increased diuresis/saluresis e.g. oedema
associated with cardiac insufficiency, renal dysfunction, trauma and parasitic disease. It is also recommended for the
treatment of mammary oedema and limb oedema.
4.3 CONTRAINDICATIONS
Do not use in cases of liver coma, renal deficiency with anuria, electrolyte deficiency (hypokalemia, hyponatremia),
hypotony and sulfonamide allergy.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Clinical experience with dogs indicates that improved results can be frequently achieved by supplementary
administration of corticosteroids.
Each ml contains:
ACTIVE SUBSTANCE
Furosemide
50 mg
(as monoethanolamine salt)
EXCIPIENTS:
Benzyl alcohol
15.0 mg
Sodium sulphite, anhydrous
1.8 mg
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 30/06/2016_
_CRN 7023977_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
When cardiac glycosides are used, furosemide should be applied only for the first 3 days.
In dogs after a simultaneous use of furosemide and digoxin preparations an undesired increased digoxin-effect may
occur. Therefore it is recommended to reduce the digox
Citiți documentul complet
